PhoreMost Achieves Target Discovery Milestone with Boehringer Ingelheim
PhoreMost Ltd., a British biopharmaceutical company, announced that their partnership with Boehringer Ingelheim on several projects to find new drug targets has led to a milestone payment. This was made possible by PhoreMost’s discovery...
Study shows Cannabis terpenes provide pain relief, contribute to ‘entourage effect’
Credit: University of Arizona Health Sciences/Noelle Haro-Gomez
When it comes to the medicinal and therapeutic properties of Cannabis sativa, an unsolved mystery is whether there exists an...
Sylvester receives 2 US Department of Defense grants to study endometrial cancer in Black...
MIAMI, FLORIDA (March 20, 2024) – Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have received two new three-year, $1 million grants from the U.S. Department of...
Calluna Pharma successfully completes Phase 1 clinical study of CAL101, a first-in-class therapeutic for...
Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced the completion of Phase 1 clinical study for CAL101, Calluna’s lead product candidate. The...
Cytiva Introduces FlexFactory to Poland
SyVento Biotech, a CDMO, opened its new mRNA manufacturing facility, a FlexFactory delivered by Cytiva, spanning over 7,000 m2, including lab and production areas, offices, and shared spaces. It establishes SyVento Biotech as a...
Polyplus-transfection expands GMP portfolio to provide additional flexibility for gene and cell therapy developers
Dec 6 2019
Polyplus-transfection(R) SA, the leading biotechnology company that supports gene and cell therapy by supplying innovative transfection solutions, today announces the availability of the first GMP-grade transfection reagent PEIpro(R)-GMP in additional conditioning that...
Promising Results: Anti-Amyloid Drug May Halt Progression of Alzheimer’s Dementia
An experimental breakthrough in the field of Alzheimer’s disease treatment has erupted through recent promising findings. A long-term clinical trial led by the esteemed Knight Family Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), based at...
Up-to-$2B Sanofi Collaboration Pays Off for Kymera
Through a pair of recent clinical milestones, Kymera Therapeutics continues to cash in on its up-to-$2 billion collaboration with Sanofi to develop first-in-class targeted protein degradation (TPD) therapies for patients with immune-inflammatory diseases.
Kymera this...
Kerry makes two biotechnology acquisitions – DairyReporter.com
The company has announced that it has reached agreement to acquire German biotechnology innovation company c-LEcta, while also confirming that it has acquired the Mexican based enzyme manufacturer, Enmex.c-LEcta is a biotechnology innovation company...
Trump Administration Proposes Deregulatory Shift on Agricultural Biotechnology – CSPI Newsroom
Article
Statement of CSPI Biotechnology Director Greg Jaffe
June 12, 2019
If American consumers are going to see the benefits of foods made with genetic engineering or gene editing technology, they will need to have...
